Clinical Trials Logo
  1. Home
  2. Neurological Disorders
  3. NCT05212727

Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders

Neurological Disorders Clinical Trial

Official title:
Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders

Clinical Trial Summary

This study aims to develop and validate a sensitive and non-invasive eye-tracking software application. This study will obtain participant responses to brief cognitive tests designed to evaluate several key functions known to be affected by neurological disorders and non-invasive eye movement measurements in response to visually presented stimuli during specifically designed eye-tracking tests. The study data will be used to develop machine learning algorithms and validate a software application intended to track the progressive component of neurological disorders and associated cognitive changes.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05212727
Study type Observational
Source Innodem Neurosciences
Contact
Status Suspended
Phase
Start date April 15, 2022
Completion date May 3, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT01589289 - Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC Phase 3
Completed NCT00010881 - Oregon Center for Complementary and Alternative Medicine in Neurological Disorders N/A
Recruiting NCT04461821 - Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents
Completed NCT04094571 - Muscle Delay Characterization N/A
Completed NCT04072536 - Evaluation on Standardized Circuits of the Interest of a Robotic Module of Assistance to the Driving N/A
Recruiting NCT02795052 - Neurologic Stem Cell Treatment Study N/A
Completed NCT02219269 - A Complex Contraception Registry N/A
Completed NCT00122174 - Stress-Busting Program for Caregivers of Patients With Neruological Diseases N/A
Recruiting NCT01524276 - Product Surveillance Registry
Completed NCT00532571 - Effects of Coenzyme Q10 in PSP and CBD Phase 2/Phase 3
Completed NCT05830981 - Valproic Acid Use in Patients With Neurological Disorders
Completed NCT01754168 - Amyloid Beta and Cognition in Parkinson Disease N/A
Completed NCT02780531 - Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases
Completed NCT01858350 - Comparison of the Effectiveness of CAM Therapies in Pediatric Patients Undergoing Sedation N/A
Recruiting NCT01266382 - The Effect of AposTherapy on the Level of Pain, Function and Quality of Life in Patients With Neuro-muscular and Neurological Disorders N/A